×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
COGT – cogent biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
COGT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/8
12:13 pm
cogt
Cogent Biosciences (NASDAQ:COGT) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Low
Report
Cogent Biosciences (NASDAQ:COGT) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
12/8
11:41 am
cogt
Cogent Biosciences (NASDAQ:COGT) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
Low
Report
Cogent Biosciences (NASDAQ:COGT) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
12/8
07:30 am
cogt
Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
Low
Report
Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
12/6
09:30 am
cogt
Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH)
Medium
Report
Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH)
11/25
01:49 pm
cogt
Cogent Biosciences (NASDAQ:COGT) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Cogent Biosciences (NASDAQ:COGT) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
11/16
11:28 am
cogt
Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress [Yahoo! Finance]
Low
Report
Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress [Yahoo! Finance]
11/14
08:00 am
cogt
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference
Low
Report
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference
11/13
08:11 am
cogt
Cogent Biosciences (NASDAQ:COGT) had its price target raised by analysts at HC Wainwright from $21.00 to $50.00. They now have a "buy" rating on the stock.
Medium
Report
Cogent Biosciences (NASDAQ:COGT) had its price target raised by analysts at HC Wainwright from $21.00 to $50.00. They now have a "buy" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/8
04:06 pm
cogt
Form 8-K Cogent Biosciences, Inc. For: Dec 06
Medium
Report
Form 8-K Cogent Biosciences, Inc. For: Dec 06
11/18
04:10 pm
cogt
Form 8-K Cogent Biosciences, Inc. For: Nov 18
Medium
Report
Form 8-K Cogent Biosciences, Inc. For: Nov 18
11/17
04:37 pm
cogt
Form SCHEDULE 13D/A Cogent Biosciences, Inc. Filed by: Fairmount Funds Management LLC
Low
Report
Form SCHEDULE 13D/A Cogent Biosciences, Inc. Filed by: Fairmount Funds Management LLC
11/14
04:58 pm
cogt
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Commodore Capital LP
Low
Report
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Commodore Capital LP
11/14
04:43 pm
cogt
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Paradigm Biocapital Advisors LP
Low
Report
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Paradigm Biocapital Advisors LP
11/14
04:32 pm
cogt
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: TCG Crossover GP I, LLC
Low
Report
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: TCG Crossover GP I, LLC
11/14
04:23 pm
cogt
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
Low
Report
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
11/14
12:36 pm
cogt
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Kynam Capital Management, LP
Medium
Report
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Kynam Capital Management, LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: